Nokia Healthineers idalandira chilolezo cha FDA chogwiritsa ntchito mwadzidzidzi pakuyesa ma antibody a SARS-CoV-2

New York-Sabata yatha, Food and Drug Administration idapereka chilolezo cha Nokia Healthineers kugwiritsa ntchito mwadzidzidzi kwa Advia Centaur SARS-CoV-2 IgG kapena kuyesa kwa sCOVG.
Chemiluminescence immunoassay idapangidwa kuti izindikire bwino komanso kocheperako kwa immunoglobulin G kapena IgG motsutsana ndi SARS-CoV-2 mu seramu ndi plasma.Mayesowa amayendetsedwa ndi Nokia 'Advia Centaur XP, Advia Centaur XPT ndi Advia Centaur CP immunoassay systems.
Malinga ndi a FDA, mayesowa atha kugwiritsidwa ntchito ndi labotale iliyonse yovomerezeka ndi CIA poyesa zolimbitsa thupi kapena zovuta kwambiri.
Mu Marichi chaka chino, SARS-CoV-2 IgG immunoassay yoyendetsedwa ndi Nokia AG, yomwe ili ku Erlangen, Germany, pa Atellica IM analyzer, idalandira EUA kuchokera ku FDA.
Mfundo zazinsinsi.Migwirizano ndi zokwaniritsa.Copyright © 2021 GenomeWeb, gawo la bizinesi la Crain Communications.maumwini onse ndi otetezedwa.